<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Megakaryocyte mass and effective platelet production in megakaryocyte disorders</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Megakaryocyte mass and effective platelet production in megakaryocyte disorders</h1>
<div class="graphic"><div class="figure"><div class="ttl">Megakaryocyte mass and effective platelet production in megakaryocyte disorders</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Bone marrow analysis was performed in normal subjects and patients with a variety of hematological conditions: hypoplastic bone marrow states (Hypo), B12 deficiency (B12 def), congestive splenomegaly (Congest), immune thrombocytopenia (ITP), chronic inflammation (Inflam), and essential thrombocythemia (ET). Left panel: The megakaryocyte mass was markedly reduced in hypoplastic bone marrow states but variably increased in all other conditions. Right panel: Effective platelet production, as determined by platelet kinetic study, was significantly reduced only in hypoplastic bone marrow states and B12 deficiency and variably increased in all other conditions.</div><div class="graphic_reference">Data from: Harker LA, Finch CA. J Clin Invest 1969; 48:963.</div><div id="graphicVersion">Graphic 60387 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
